CAS: 1446790-62-0
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | RO9021 REF: AN-AG00ABT7CAS: 1446790-62-0 | 99% | 160,00 €~4.157,00 € | Mié 08 May 24 |
 | RO9021 REF: TM-T16776CAS: 1446790-62-0 | 98% | 85,00 €~2.211,00 € | Mié 15 May 24 |
 | RO9021 REF: 3D-WHC79062CAS: 1446790-62-0 | Min. 95% | A consultar | Jue 20 Jun 24 |
Ref: AN-AG00ABT7
| 1mg | 160,00 € | |
| 5mg | 597,00 € | |
| 10mg | 648,00 € | |
| 25mg | 1.048,00 € | |
| 50mg | 1.429,00 € | |
| 100mg | 2.079,00 € | |
| 500mg | 4.157,00 € |
Entrega estimada en Estados Unidos, el Miércoles 8 de Mayo de 2024
RO9021
CAS:1446790-62-0
RO9021 is an orally bioavailable, novel ATP-competitive SYK inhibitor (average IC50: 5.6 nM).
Fórmula:
C18H25N7O
Pureza:
98%
Forma y color:
Solid
Peso molecular:
355.44
Ref: TM-T16776
| 1mg | 85,00 € | |
| 5mg | 222,00 € | |
| 10mg | 337,00 € | |
| 25mg | 573,00 € | |
| 50mg | 811,00 € | |
| 100mg | 1.096,00 € | |
| 500mg | 2.211,00 € |
Entrega estimada en Estados Unidos, el Miércoles 15 de Mayo de 2024
RO9021
CAS:1446790-62-0
RO9021 is a novel, orally bioavailable, small-molecule CDK4/6 inhibitor that blocks the cell cycle at …
Fórmula:
C18H25N7O
Pureza:
Min. 95%
Peso molecular:
355.44 g/mol
Ref: 3D-WHC79062
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 20 de Junio de 2024
